Vienna (Austria), Nantes (France) May 14, 2013 – Intercell AG (Intercell, VSE; “ICLL”) and Vivalis SA (Vivalis, NYSE Euronext; “VLS”) today announced that the final administrative step for closing of the proposed merger between the two companies to create Valneva SE (Valneva) has been initiated by filing of the relevant documents with the companies’ register at the Commercial Court of Lyon. This step follows the approval of the proposed merger by the extraordinary general meetings of both companies, the issuance of the pre-merger certificates by the French Commercial Register on April 3, 2013 and by the Austrian Commercial Register on April 12, 2013, and the issuance of the certificate of legality of the merger on April 17, 2013. Subject to the registration decision by the Court of Lyon, the completion of the merger is expected for May 28, 2013 and will have the following impact on shares and trading:
Automatic exchange of Intercell shares
On the expected closing date May 28, 2013, Intercell shareholders will receive 13 new ordinary shares and 13 new preferred shares of Valneva for every 40 Intercell shares (ISIN AT0000612601) that they own. The exchange of the shares will be executed automatically and without costs for shareholders. Fractional entitlements of less than one new Valneva share will be sold on the stock market and proceeds will be credited to each shareholders account free of all charges. Vivalis shares (ISIN FR0004056851) will not be affected by any share exchange and continue to exist under the new name of Valneva. The Valneva shares will be traded on both the NYSE Euronext Paris and the Vienna Stock Exchange.
Share trading on the Vienna Stock Exchange
Intercell shares will be suspended from trading on the Vienna Stock Exchange at close of business of May 21, 2013 in order to enable the settlement of all orders before the exchange into Valneva ordinary and preferred shares. Valneva ordinary shares (ISIN FR0004056851) will start trading in the Prime Market segment of the Vienna Stock Exchange on May 28, 2013 under the ticker symbol “VLA” and will continue to be listed on the regulated market of NYSE Euronext in Paris under the ticker symbol “VLS.PA”. Valneva preferred shares (ISIN FR0011472943) will start trading on May 28, 2013 on the regulated market of NYSE Euronext in Paris under ticker symbol “VLSpr.PA” and on the unregulated Third Market Segment of the Vienna Stock Exchange under the ticker symbol “VLAP”.
Visit link: Intercell AG (INRLY: OTCQX International) | Merger between Intercell and Vivalis planned to complete on May 28, 2013 – Relevant documents filed with the Commercial Court of Lyon
In Recognition of Outstanding International Commercial Achievement, Leading Providers of Intelligent Visual Solutions Receive the UK’s Highest Accolade for Business Success
Read this article: Queen’s Award for Enterprise Awarded to Symon Dacon, Now Trading as RMG Networks Ltd.
< ?xml version="1.0" encoding="UTF-8"?>
Hemp, Inc. to Co-Produce Historic Documentary on Commercial-Scale Planting of Hemp
DENVER, May 13, 2013
DENVER, May 13, 2013 /PRNewswire/ — After 60 years of industrial hemp growing dormancy in America, hemp grower, Ryan Loflin is set to revitalize commercial-scale hemp growing today in Springfield, Colorado. The historical event will be filmed with Hemp, Inc. (OTC: HEMP), the leader in the industrial hemp industry, serving as one of the Executive Producers.
MARTINSRIED, GERMANY and MUNICH, GERMANY–(Marketwired – May 10, 2013) – MorphoSys AG
(FSE: MOR; Prime Standard Segment; TecDAX) announced today that a
first scientific publication on the Company’s novel, proprietary
platform Ylanthia was published in the current issue of “mAbs”. The
titled “A fully synthetic human Fab antibody library based on fixed
framework pairings with favorable biophysical properties” describes
first time the detailed design, generation and testing of the Ylanthia
Ylanthia became commercially available for existing and new partners in
is currently used in two commercial agreements.
Go here to see the original: MorphoSys Announces First Scientific Publication on Novel Antibody Platform Ylanthia
Carmaker General Motors (GM) says it is withdrawing a TV commercial for its Chevrolet Trax four-wheel drive after its soundtrack was deemed “offensive”.
Read the original here: GM withdraws ‘offensive’ car ad
Eastman Kodak says it expects to exit bankruptcy as early as July in its new guise as a commercial imaging firm.
View post: Kodak unveils post-bankruptcy plan
An Ethiopian Airlines 787 Dreamliner is due to take off from Addis Ababa on Saturday morning, the first commercial flight by the Boeing aircraft since all 787s were grounded in January.
Read more: VIDEO: New batteries give Dreamliner take-off
LOUISVILLE, KENTUCKY–(Marketwired – April 24, 2013) - The Federal Motor Carriers Safety Administration (FMCSA) has announced that devices such as tablets, Electronic Logging Devices (ELDs) and smartphones are now defined as meeting the interpretation of a “Commercial Mobile Radio Service (CMRS) transponder” under the Commercial Vehicle Information Systems and Networks (CVISN) program.
Excerpt from: State Agencies That Adopt Drivewyze Could Meet Core CVISN Requirements for e-Screening
CALGARY, ALBERTA–(Marketwired – April 9, 2013) - Kulczyk Oil Ventures Inc. (WARSAW:KOV) (“Kulczyk Oil“, “KOV” or the “Company“), an international upstream oil and gas exploration and production company, is very pleased to announce a new pool gas discovery on the Makeevskoye Licence in Ukraine. The Makeevskoye-16 (“M-16“) exploration well has tested gas from the S5 zone at more than 4.3 million cubic feet per day (“MMcf/d“). M-16 is the deepest well drilled by the Company in Ukraine and this is the first time the Company has tested gas at commercial rates from a reservoir of Serpukhovian age, opening up new opportunities for future growth.
Read the original here: Kulczyk Oil Ventures Inc.: Ukraine-New Deep Gas Discovery Tests Gas at 4.3 MMcf/d
Two major sports management firms team up to win more commercial endorsements in India and the Middle East for UK tennis player Andy Murray.
Here is the original post: Murray targets India and Middle East